Pregnancy Medication Market Analysis

Pregnancy Medication Market Analysis

To get key market trends

  Download Free Sample

Pregnancy medication market from nutritional supplements segment garnered revenues worth over USD 16.5 billion in 2022. Nutritional supplements comprising omega-3, vitamins, minerals, folic acid, multivitamins, and others support the development of the placenta and fetus while preventing the risk of neural tube defects. The growing emphasis on maintaining a healthy diet to minimize the prospects of birth defects and improper nutrition in babies will propel the segment size.
 

The 2nd-trimester segment is expected to exhibit over 13% CAGR from 2023 to 2032. The intake of pregnancy medications and supplements in the 2nd-trimester improves sensory gating and reduces the risk of later attention deficits and psychological disorders. Health complications such as separation of the placenta from the uterus, increased preterm labor, and other risk factors are quite prevalent during the 4th to 6th months of pregnancy. Hence, in light of these complications, the pregnancy medication demand will accelerate throughout the projection period.
 

Pregnancy medication market from retail pharmacy segment is anticipated to amass nearly 28% business share by 2032. Retail pharmacies are easily accessible to patients and have the availability of a broad range of healthcare products and everyday items. These establishments are equipped with skilled pharmacists offering uniquely tailored personalized advice to patients based on their health issues. Access to high-quality consumer service at affordable prices across these settings will help retail pharmacies emerge as major expansion contributors in the ensuing years.
 

Europe pregnancy medication market is slated to cross USD 23 billion by 2032. The increasing number of market participants organizing social media campaigns and health initiatives to create awareness about proper health and diet among pregnant women will stimulate the regional market landscape. In addition, the growing incidences of birth defects and congenital anomalies, coupled with the availability of high-quality health supplements, will positively influence the industry dynamics across Europe.